{"transactions":[{"id":1943564,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-21T21:28:43.000Z","date":"2023-01-14","kind":"other","planned":false,"acquired":false,"shares":5000,"price":2.75,"value":13750.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Mr. Jacobs passed away January 14, 2023.  All unvested equity awards forfeited upon death."}],"balance_after":98415,"source":{"system":"sec-edgar","filing":"0001209191-23-020351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919123020351/doc4.xml","form_type":"4"}},{"id":2288133,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T17:05:47.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":5000,"price":2.59,"value":12950.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 16, 2023."}],"balance_after":103415,"source":{"system":"sec-edgar","filing":"0001209191-22-026144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122026144/doc4.xml","form_type":"4"}},{"id":2672596,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-11T21:20:26.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":5000,"price":3.22,"value":16100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2022."}],"balance_after":98415,"source":{"system":"sec-edgar","filing":"0001209191-21-039934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039934/doc4.xml","form_type":"4"}},{"id":3174613,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-17T21:22:08.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":5000,"price":3.56,"value":17800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 23, 2021."}],"balance_after":93415,"source":{"system":"sec-edgar","filing":"0001209191-20-024892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024892/doc4.xml","form_type":"4"}},{"id":3506642,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-23","kind":"purchase","acquired":true,"shares":850,"price":6.44,"value":5474.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":88415,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506641,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-22","kind":"purchase","acquired":true,"shares":850,"price":6.49,"value":5516.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":87565,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506640,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-21","kind":"purchase","acquired":true,"shares":850,"price":6.49,"value":5516.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":86715,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506639,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-20","kind":"purchase","acquired":true,"shares":850,"price":6.89,"value":5856.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":85865,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506638,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-17","kind":"purchase","acquired":true,"shares":794,"price":6.2,"value":4922.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":85015,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506637,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-16","kind":"purchase","acquired":true,"shares":301,"price":5.99,"value":1802.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":84221,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506636,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-15","kind":"purchase","acquired":true,"shares":677,"price":6,"value":4062.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":83920,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506635,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-14","kind":"purchase","acquired":true,"shares":66,"price":5.48,"value":361.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":83243,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506634,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-13","kind":"purchase","acquired":true,"shares":526,"price":5.67,"value":2982.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":83177,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3506633,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T21:12:38.000Z","date":"2019-05-10","kind":"purchase","acquired":true,"shares":931,"price":5.92,"value":5511.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":82651,"source":{"system":"sec-edgar","filing":"0001209191-19-033695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119033695/doc4.xml","form_type":"4"}},{"id":3532096,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-05-08","kind":"purchase","acquired":true,"shares":933,"price":6.26,"value":5840.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":81720,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532095,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-05-07","kind":"purchase","acquired":true,"shares":361,"price":5.83,"value":2104.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":80787,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532094,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-05-06","kind":"purchase","acquired":true,"shares":686,"price":6.16,"value":4225.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":80426,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532093,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-05-02","kind":"purchase","acquired":true,"shares":748,"price":5.38,"value":4024.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":79740,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532092,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-05-01","kind":"purchase","acquired":true,"shares":441,"price":5.51,"value":2429.91,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":78992,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532091,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-04-30","kind":"purchase","acquired":true,"shares":98,"price":5.74,"value":562.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":78551,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532090,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-04-29","kind":"purchase","acquired":true,"shares":343,"price":5.81,"value":1992.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":78453,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3532089,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T21:15:49.000Z","date":"2019-04-26","kind":"purchase","acquired":true,"shares":236,"price":5.92,"value":1397.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":78110,"source":{"system":"sec-edgar","filing":"0001209191-19-029024","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119029024/doc4.xml","form_type":"4"}},{"id":3547948,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-25","kind":"purchase","acquired":true,"shares":385,"price":5.94,"value":2286.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":77874,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547947,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-24","kind":"purchase","acquired":true,"shares":86,"price":5.97,"value":513.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":77489,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547946,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"CommonStock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-23","kind":"purchase","acquired":true,"shares":392,"price":5.98,"value":2344.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":77403,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547945,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-22","kind":"purchase","acquired":true,"shares":49,"price":6.12,"value":299.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":77011,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547944,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-17","kind":"purchase","acquired":true,"shares":484,"price":6.09,"value":2947.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":76962,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547943,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-16","kind":"purchase","acquired":true,"shares":49,"price":6.22,"value":304.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":76478,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547942,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-15","kind":"purchase","acquired":true,"shares":784,"price":6.15,"value":4821.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":76429,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547941,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-12","kind":"purchase","acquired":true,"shares":490,"price":6.26,"value":3067.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":75645,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547940,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-11","kind":"purchase","acquired":true,"shares":139,"price":6.17,"value":857.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":75155,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3547939,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-26T21:30:20.000Z","date":"2019-04-10","kind":"purchase","acquired":true,"shares":850,"price":6.29,"value":5346.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":75016,"source":{"system":"sec-edgar","filing":"0001209191-19-026277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119026277/doc4.xml","form_type":"4"}},{"id":3556907,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-09","kind":"purchase","acquired":true,"shares":850,"price":6.31,"value":5363.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":74166,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3556906,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-08","kind":"purchase","acquired":true,"shares":850,"price":5.89,"value":5006.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":73316,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3556905,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-05","kind":"purchase","acquired":true,"shares":183,"price":6.32,"value":1156.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":72466,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3556904,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-04","kind":"purchase","acquired":true,"shares":241,"price":6.19,"value":1491.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":72283,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3556903,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":80,"price":6,"value":480.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":72042,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3556902,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-02","kind":"purchase","acquired":true,"shares":580,"price":6.12,"value":3549.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":71962,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3556901,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-12T21:15:22.000Z","date":"2019-04-01","kind":"purchase","acquired":true,"shares":382,"price":5.99,"value":2288.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019."}],"balance_after":71382,"source":{"system":"sec-edgar","filing":"0001209191-19-024498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119024498/doc4.xml","form_type":"4"}},{"id":3581989,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-22T21:15:41.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":5000,"price":5.98,"value":29900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 18, 2020."}],"balance_after":71000,"source":{"system":"sec-edgar","filing":"0001209191-19-021034","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021034/doc4.xml","form_type":"4"}},{"id":3603876,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Options (right to buy)","published_at":"2019-03-08T17:01:28.000Z","date":"2019-03-07","kind":"exercise","acquired":false,"shares":18315,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":15.96,"exercise_date":"2014-03-19","expiration_date":"2019-03-16","underlying":"Common Stock","underlying_shares":18315},"source":{"system":"sec-edgar","filing":"0000899243-19-006933","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924319006933/doc4.xml","form_type":"4"}},{"id":3603875,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-08T17:01:28.000Z","date":"2019-03-07","kind":"exercise","acquired":true,"shares":18315,"price":15.96,"value":292307.4,"ownership":{"direct":true},"balance_after":266388,"source":{"system":"sec-edgar","filing":"0000899243-19-006933","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924319006933/doc4.xml","form_type":"4"}},{"id":3660016,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-13T17:04:26.000Z","date":"2018-12-16","kind":"tax_withholding","acquired":false,"shares":36126,"price":28.93,"value":1045125.18,"ownership":{"direct":true},"balance_after":248073,"source":{"system":"sec-edgar","filing":"0000899243-19-003449","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924319003449/doc5.xml","form_type":"5"}},{"id":3790552,"issuer":{"id":162981,"kind":"organization","name":"Envision Healthcare Corp","symbol":"EVHC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-15T12:52:48.000Z","date":"2018-10-11","kind":"disposition_to_issuer","acquired":false,"shares":17472,"price":46,"value":803712.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"At the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Company Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 4,017 restricted stock unit awards (\"Company RSUs\"). At the Effective Time, each Company RSU that was outstanding as of immediately prior to the Effective Time was converted into the right to receive an amount in cash equal to the sum of (i) the product of (A) the total number of shares of Company Common Stock subject to such Company RSU immediately prior to the Effective Time and (B) the Merger Consideration and (ii) any accrued but unpaid dividend equivalents with respect to such Company RSU."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"At the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Company Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Merger Agreement) was cancelled and converted into the right to receive $46.00 in cash, (the \"Merger Consideration\") without interest and subject to applicable withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001678531-18-000149","document":"wf-form4_153962235290865.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000167853118000149/wf-form4_153962235290865.xml","form_type":"4"}},{"id":3915214,"issuer":{"id":162981,"kind":"organization","name":"Envision Healthcare Corp","symbol":"EVHC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-29T18:16:12.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":4017,"price":43.57,"value":175020.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the annual restricted stock unit award granted to non-employee directors for service on the Company's board of directors (the \"Board\"). The restricted stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board, and will be settled upon vesting."}],"balance_after":17472,"source":{"system":"sec-edgar","filing":"0001678531-18-000081","document":"wf-form4_152763211453699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000167853118000081/wf-form4_152763211453699.xml","form_type":"4"}},{"id":3984179,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-23T21:41:28.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":5000,"price":6.7,"value":33500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 20, 2019."}],"balance_after":66000,"source":{"system":"sec-edgar","filing":"0001209191-18-021465","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021465/doc4.xml","form_type":"4"}},{"id":4007858,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-07T20:24:03.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":42747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 4-year period in equal yearly installments beginning March 2, 2019."}],"balance_after":284199,"source":{"system":"sec-edgar","filing":"0000899243-18-006751","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924318006751/doc4.xml","form_type":"4"}},{"id":4019543,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-02T17:03:18.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":26335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares received upon vesting of performance vesting restricted stock units awarded on March 29, 2017."}],"balance_after":241452,"source":{"system":"sec-edgar","filing":"0000899243-18-006150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924318006150/doc4.xml","form_type":"4"}},{"id":4019542,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-02T17:03:18.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":13621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015."}],"balance_after":215117,"source":{"system":"sec-edgar","filing":"0000899243-18-006150","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924318006150/doc4.xml","form_type":"4"}},{"id":4227407,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-22T18:13:10.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":300000,"price":50.69,"value":15207000.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Mr. Jacobs expressly disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"By the Jeremy Brent Jacobs GST Non-Exempt u/a/d 04/26/2011 and Scott Douglas Jacobs GST Non-Exempt Trust u/a/d 04/26/2011."}],"balance_after":267649,"source":{"system":"sec-edgar","filing":"0000899243-17-020878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317020878/doc4.xml","form_type":"4"}},{"id":4227406,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-22T18:13:10.000Z","date":"2017-08-22","kind":"sale","acquired":false,"shares":200000,"price":50.69,"value":10138000.0,"ownership":{"direct":true},"balance_after":201496,"source":{"system":"sec-edgar","filing":"0000899243-17-020878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317020878/doc4.xml","form_type":"4"}},{"id":4296522,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-02T21:23:13.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":4000,"price":6.53,"value":26120.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on May 19, 2018."}],"balance_after":61000,"source":{"system":"sec-edgar","filing":"0001209191-17-037368","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117037368/doc4.xml","form_type":"4"}},{"id":4301083,"issuer":{"id":162981,"kind":"organization","name":"Envision Healthcare Corp","symbol":"EVHC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-30T19:38:32.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":3124,"price":56.03,"value":175037.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the annual restricted stock unit award granted to non-employee directors for service on the Company's board of directors (the \"Board\"). The restricted stock units vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the Company's next annual shareholders meeting, in each case subject to continued service on the Board, and will be settled upon vesting."}],"balance_after":13455,"source":{"system":"sec-edgar","filing":"0001678531-17-000132","document":"wf-form4_149618749639323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000167853117000132/wf-form4_149618749639323.xml","form_type":"4"}},{"id":4356253,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-07T21:06:13.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":1000,"price":6.45,"value":6450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2018."}],"balance_after":57000,"source":{"system":"sec-edgar","filing":"0001209191-17-026326","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026326/doc4.xml","form_type":"4"}},{"id":4366650,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-31T17:10:32.000Z","date":"2017-03-29","kind":"tax_withholding","acquired":false,"shares":1971,"price":43.59,"value":85915.89,"ownership":{"direct":true},"balance_after":401496,"source":{"system":"sec-edgar","filing":"0000899243-17-009040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317009040/doc4.xml","form_type":"4"}},{"id":4366649,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-31T17:10:32.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":39986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares will vest over a 4-year period in equal annual installments beginning March 29, 2018."}],"balance_after":403467,"source":{"system":"sec-edgar","filing":"0000899243-17-009040","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317009040/doc4.xml","form_type":"4"}},{"id":4382187,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-16T18:04:44.000Z","date":"2017-03-14","kind":"tax_withholding","acquired":false,"shares":24756,"price":42.77,"value":1058814.12,"ownership":{"direct":true},"balance_after":363481,"source":{"system":"sec-edgar","filing":"0000899243-17-007805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317007805/doc4.xml","form_type":"4"}},{"id":4382186,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-16T18:04:44.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":15819,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares received upon vesting of performance vesting restricted stock units awarded on February 27, 2014."}],"balance_after":388237,"source":{"system":"sec-edgar","filing":"0000899243-17-007805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317007805/doc4.xml","form_type":"4"}},{"id":4382185,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-16T18:04:44.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":29298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares received upon vesting of performance vesting restricted stock units awarded on February 24, 2015."}],"balance_after":372418,"source":{"system":"sec-edgar","filing":"0000899243-17-007805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317007805/doc4.xml","form_type":"4"}},{"id":4382184,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-16T18:04:44.000Z","date":"2017-03-14","kind":"grant","acquired":true,"shares":13899,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares received upon vesting of performance vesting restricted stock units awarded on February 5, 2016."}],"balance_after":343120,"source":{"system":"sec-edgar","filing":"0000899243-17-007805","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317007805/doc4.xml","form_type":"4"}},{"id":4417156,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-28T17:00:38.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":1374,"price":44.94,"value":61747.56,"ownership":{"direct":true},"balance_after":329221,"source":{"system":"sec-edgar","filing":"0000899243-17-005579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317005579/doc4.xml","form_type":"4"}},{"id":4417155,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-28T17:00:38.000Z","date":"2017-02-24","kind":"tax_withholding","acquired":false,"shares":1413,"price":43.24,"value":61098.12,"ownership":{"direct":true},"balance_after":330595,"source":{"system":"sec-edgar","filing":"0000899243-17-005579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317005579/doc4.xml","form_type":"4"}},{"id":4463909,"issuer":{"id":4312,"kind":"organization","name":"Acadia Healthcare Company, Inc."},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-07T18:03:48.000Z","date":"2017-02-05","kind":"tax_withholding","acquired":false,"shares":1923,"price":38.8,"value":74612.4,"ownership":{"direct":true},"balance_after":332008,"source":{"system":"sec-edgar","filing":"0000899243-17-002958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000089924317002958/doc4.xml","form_type":"4"}},{"id":4535065,"issuer":{"id":162981,"kind":"organization","name":"Envision Healthcare Corp","symbol":"EVHC"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-02T16:59:21.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":10331,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Acquisition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings, Inc., Envision Healthcare Corporation (formerly known as New Amethyst Corp.) (the \"Company\") and AmSurg Corp. (the \"Merger Agreement\"), exempt under Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of AmSurg Corp. common stock held by the reporting person immediately prior to the Merger 1 Effective Time  was assumed by the Company and converted into one share of the Company's common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, equity-based awards granted pursuant to AmSurg Corp. plans that were outstanding immediately prior to the effective time of the Mergers were converted into corresponding awards in respect of the Company's common stock at the effective time of the Mergers, subject to the same terms and conditions (including applicable vesting requirements) as were applicable to such awards prior to the consummation of the Mergers; provided, that AmSurg Corp.'s outstanding performance awards issued pursuant to the Performance Share Unit Award Agreement (the \"Agreement\") under its 2014 Equity and Incentive Plan (the \"Plan\") that were eligible to vest settled into shares of restricted stock at the Target Award (as defined in the Agreement) upon consummation of the Mergers, as the Mergers constituted a Change of Control (as defined in the Plan)."}],"balance_after":10331,"source":{"system":"sec-edgar","filing":"0001678531-16-000069","document":"wf-form4_148071594902136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243878/000167853116000069/wf-form4_148071594902136.xml","form_type":"4"}},{"id":4537756,"issuer":{"id":180763,"kind":"organization","name":"AMSURG CORP","symbol":"AMSG"},"owners":[{"id":115333,"kind":"person","name":"JACOBS JOEY A","position":1,"cik":"0001243878","reported_name":"JACOBS JOEY A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2016-12-01T16:36:13.000Z","date":"2016-12-01","kind":"disposition_to_issuer","acquired":false,"shares":10331,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition pursuant to the terms of the Agreement and Plan of Merger, dated as of June 15, 2016, by and among Envision Healthcare Holdings,Inc., New Amethyst Corp. and AmSurg Corp. (the \"Merger Agreement\"), exempt under Rule 16b-3."},{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time  was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Merger Agreement, at the Merger 1 Effective Time (as defined in the Merger Agreement), each share of common stock held by the reporting person immediately prior to the Merger 1 Effective Time  was assumed by New Amethyst and converted into a New Amethyst share of common stock having the same terms and conditions, taking into account any changes thereto by reason of the Mergers (as defined in the Merger Agreement)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000895930-16-000291","document":"wf-form4_148062816063861.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/895930/000089593016000291/wf-form4_148062816063861.xml","form_type":"4"}}]}